Introduction
============

The catecholamine dopamine is a neurotransmitter in the human brain. Dopaminergic neurons can be divided into four major pathways: nigrostriatal, mesolimbic, mesocortical and tuberoinfundibular ([@ref-2]; [@ref-13]). These neurons play an important role in voluntary movement, feeding, reward and learning, as well as certain other functions. Outside the brain, dopamine takes on a physiological role in cardiovascular functions, hormonal regulation, renal and other functions ([@ref-44]; [@ref-33]; [@ref-42]; [@ref-9]; [@ref-27]). Due to this involvement in many different processes and systems, dopamine is also related to a variety of diseases. Parkinson's disease, caused by a loss of dopaminergic innervations in the striatum, is a prominent example ([@ref-17]). Additionally, the expected associations between the dopaminergic system and schizophrenia stem from the fact that various dopamine receptor 2 blockers are used as antipsychotics in treating that condition ([@ref-44]; [@ref-12]; [@ref-40]; [@ref-10]). Further relationships with dopamine dysregulation are expected in Tourette's syndrome and attention deficit hyperactivity disorder (ADHD) ([@ref-32]; [@ref-46]; [@ref-21]). The strong involvement of dopamine in the reward system suggests an association with drug abuse and addiction ([@ref-25]; [@ref-15]; [@ref-30]). Many more diseases and conditions are expected to involve dopamine dysfunctions. (As reviewed by [@ref-6]).

In humans, five different dopamine receptors exist. They are classified into two categories based on their structure and their pharmacological and biochemical properties. The D1-class includes the dopamine receptors 1 and 5, while the D2-class consists of the dopamine receptors 2, 3 and 4 ([@ref-3]; [@ref-37]; [@ref-43]; [@ref-45]; [@ref-11]; [@ref-48]). The focus of our study is on the dopamine receptor 2 and its gene *DRD2*. The dopamine receptor 2 gene lies on the long arm of chromosome 11 (11q23.1). It spans from 113,280,317 to 113,346,413 for a total of 66,096 base pairs (bp) (information accessed on NCBI in the GnRH37 assembly). For the gene card, see [Fig. 1](#fig-1){ref-type="fig"}. *DRD2* has six introns ([@ref-19]). Alternative splicing between intron 4 and 5 of an 87 bp exon generates two variants of the dopamine receptor 2. The difference between D2S (short) and D2L (long) is a 29-amino-acids-long chain in the third intercellular loop of the protein ([@ref-20]; [@ref-35]). While the short form (D2S) is mainly expressed at the presynapse, the long form (D2L) is expressed postsynaptically ([@ref-47]; [@ref-14]). The D2S are mainly autoreceptors, i.e., they reduce the expression of dopamine when activated. This leads to an important negative feedback mechanism ([@ref-50]; [@ref-33]; [@ref-42]). (Again, as reviewed by [@ref-6]).

![Location of candidate SNPs under balancing selection in *DRD2*.\
E1-8 are exons 1 to 8. (1) [rs60599314](http://www.ncbi.nlm.nih.gov/snp/?term=rs60599314), (2) [rs79549222](http://www.ncbi.nlm.nih.gov/snp/?term=rs79549222), (3) [rs12574471](http://www.ncbi.nlm.nih.gov/snp/?term=rs12574471), (4) [rs80215768](http://www.ncbi.nlm.nih.gov/snp/?term=rs80215768), (5) [rs76581995](http://www.ncbi.nlm.nih.gov/snp/?term=rs76581995), (6) [rs80014933](http://www.ncbi.nlm.nih.gov/snp/?term=rs80014933), (7) [rs74751335](http://www.ncbi.nlm.nih.gov/snp/?term=rs74751335), (8) [rs77264605](http://www.ncbi.nlm.nih.gov/snp/?term=rs77264605), (9) [rs76499333](http://www.ncbi.nlm.nih.gov/snp/?term=rs76499333).](peerj-03-1149-g001){#fig-1}

![Detection of outlier SNPs of the *DRD2* gene using FDIST (LOSITAN).\
*X*-axis: estimated heterozygosity values. *Y*-axis: *F~ST~*-values. The upper area indicates positive directional selection, the middle area neutrality, and the lower area balancing selection. Confidence intervals represent borders between "selection areas". See [Table S2](#supp-30){ref-type="supplementary-material"} for the exact results on the SNPs.](peerj-03-1149-g002){#fig-2}

![Graphical output of BayeScan.\
*X*-axis: log10(*q* values) for all SNPs, the threshold is −2. *Y*-axis: *F~ST~*-values, where high values indicate directional selection, low values balancing selection. For exact results see [Table S2](#supp-30){ref-type="supplementary-material"}. Squares: the nine SNPs in the MAF \> 0.05 sample that BayeScan and LOSITAN find.](peerj-03-1149-g003){#fig-3}

Among the many single nucleotide polymorphisms (SNPs) of *DRD2*, one prominent example is [rs6277](http://www.ncbi.nlm.nih.gov/snp/?term=rs6277), also known as C957T. It has been associated with schizophrenia in Han Chinese in Taiwan ([@ref-22]), in Russians ([@ref-34]) and in Bulgarians ([@ref-8]). Together with the -141C allele, the 957T allele is associated with the diagnosis of anorexia nervosa ([@ref-7]). A meta-analysis showed that the Ser311Cys polymorphism ([rs1801028](http://www.ncbi.nlm.nih.gov/snp/?term=rs1801028)) in *DRD2* is a risk factor for schizophrenia. The heterozygotes (Ser/Cys) and the homozygotes for Cys were both at elevated risk for schizophrenia when compared to the Ser/Ser genotypes ([@ref-23]). In a study with alcoholic patients and controls, the A allele of [rs1076560](http://www.ncbi.nlm.nih.gov/snp/?term=rs1076560) was more frequent in alcoholic patients ([@ref-38]). In 2012, Mileva-Seitz et al. conducted a study with Caucasian mothers and their infants. They taped mother-infant behaviour and genotyped various SNPs of *DRD2* and also *DRD1*. [rs1799732](http://www.ncbi.nlm.nih.gov/snp/?term=rs1799732) and the previously mentioned [rs6277](http://www.ncbi.nlm.nih.gov/snp/?term=rs6277) were both associated with direct vocalization of the mother towards the infant.

The body of literature on SNPs and their possible effects is growing rapidly. Considering the influences those SNPs could have on human behaviour, and bearing in mind the different ecological habitats of *Homo sapiens*, we explore if *DRD2* underwent any selection processes. In [@ref-41], an interesting proposal by [@ref-41] stated that schizophrenia was the low fitness variant of a highly variable mental trait. Based on the connection between dopamine receptor 2 and schizophrenia, as stated above, we focused our analysis on *DRD2*.

To reduce false-positives, we used two selection detection algorithms to explore *DRD2*. This exploratory ("hypothesis-free") approach is designed to find candidate SNPs that were under selection. The data basis of our analysis is the 1,000 Genomes Project samples.

Material and Methods
====================

We acquired data from the 1,000 Genomes Project (phase I) through SPSmart engine v5.1.1 (<http://spsmart.cesga.es/engines.php>; [@ref-1]), using the search term "DRD2." We included all single nucleotide polymorphisms (SNPs) with a minor allele frequency (MAF) greater than 0.05 (*N* = 151 SNPs) to include only the more frequently occurring SNPs. To verify our results also on the basis of a higher number of SNPs (which occur less frequently), we conducted the same analysis also based on a MAF \> 0.01 sample (*N* = 246 SNPs; data presented in [Supplemental Information](#supplemental-information){ref-type="supplementary-material"}). The structure of the *DRD2* gene (113,280,317--113,346,413 in the GnRH37.p13 primary assembly) is shown in [Fig. 1](#fig-1){ref-type="fig"}. The populations used for our analysis are shown in [Table 1](#table-1){ref-type="table"}.

The data were converted by hand into the CONVERT format. All further format conversions were performed by PGD Spider 2.0.5.2 ([@ref-31]).

Two different programs were used to detect selection; both use *F~ST~* approaches to detect outliers. The program LOSITAN calculates FDIST, which uses *F~ST~* and the expected heterozygosity. It assumes an island model of migration with neutral markers. An expected distribution of Wright's inbreeding coefficient is calculated and then outliers are identified. A neutral mean *F~ST~* was computed by the program before the 50,000 simulations were performed. The infinite alleles model was used. To avoid false positive detection, we set the significance level to *p* \< 0.01 (*P*(Simulation *F~ST~* \< sample *F~ST~*)) ([@ref-4]).

BayeScan is a Bayesian statistics program. Basically, it calculates two simulations for every locus: one in which it assumes the locus is under selection and the other one in which this assumption is dropped. It splits the *F~ST~* coefficient into two parts. The alpha value is a locus-specific component shared by all populations. The beta value is a population-specific component shared by all loci. This is achieved via logistic regression and provides insight into selection. The alpha value serves as an indicator for selection. Significant positive values of alpha indicate directional selection, whereas significant negative values indicate balancing selection. The posterior probabilities are estimated using a reversible-jump Markov Chain Monte Carlo (MCMC) approach. The posterior probabilities are gained by counting how many times alpha is included in the model. Before computing the Markov chains, we calculate 20 pilot runs with 5,000 iterations each. The initial burn-in is set to 50,000 steps and the chains are run with 5,000 iterations and a thinning interval of 10. The program output consists of a posterior probability, the logarithm (base 10) of the posterior odds and a *q* value. These three values are all for the model with selection. Furthermore, the alpha value is reported along with an *F~ST~* coefficient average of all population per locus. In BayeScan the threshold of a posterior *P* of \>0.99 and a log10(PO) of 2 or higher is used. This threshold is labelled as "Decisive" by BayeScan (see the program manual at <http://cmpg.unibe.ch/software/BayeScan/files/BayeScan2.1_manual.pdf>) ([@ref-18]).

To compute linkage disequilibrium (LD) of the SNPs, we used the R "genetics package" (<http://cran.r-project.org/web/packages/genetics/genetics.pdf>; [@ref-49]). [@ref-36] states that *D*′ is particularly useful to assess the probability for historical recombination in a given population and *r*^2^ is useful in the context of association studies. We therefore primarily calculate *D*′, but we also calculated *r*^2^, which is presented in [Supplemental Information](#supplemental-information){ref-type="supplementary-material"}.

In most populations one or more SNPs had to be excluded to successfully run the computation. The population IBS was excluded entirely from this computation. IBS is a very small population (*n* = 14), and 30 SNPs caused the computation to fail. For a detailed view on all excluded SNPs, see [Table S1](#supp-29){ref-type="supplementary-material"}.

We accessed information on the gene via NCBI (<http://www.ncbi.nlm.nih.gov/>) and on the specific SNPs via Ensembl (<http://www.ensembl.org/>).

Results
=======

The combined results of LOSITAN and BayeScan yielded nine candidate SNPs under balancing selection (MAF \> 0.05); see [Table 2](#table-2){ref-type="table"}. [Figure 2](#fig-2){ref-type="fig"} shows the graphical output of LOSITAN and [Fig. 3](#fig-3){ref-type="fig"} the output of BayeScan.

For a detailed view on the results of LOSITAN and BayeScan for all SNPs, see [Table S2](#supp-30){ref-type="supplementary-material"} in the supplementary material. [Figure 1](#fig-1){ref-type="fig"} provides a gene view of *DRD2* with labels for the candidate SNPs.

The same calculations based on the MAF \> 0.01 sample revealed only 2 SNPs ([rs60599314](http://www.ncbi.nlm.nih.gov/snp/?term=rs60599314), [rs79549222](http://www.ncbi.nlm.nih.gov/snp/?term=rs79549222)) under balancing selection by both LOSITAN and Bayescan ([Fig. S1](#supp-1){ref-type="supplementary-material"}, [Table S3A](#supp-31){ref-type="supplementary-material"} and [Table S3B](#supp-32){ref-type="supplementary-material"}).

Three SNPs ([rs6277](http://www.ncbi.nlm.nih.gov/snp/?term=rs6277), [rs12800853](http://www.ncbi.nlm.nih.gov/snp/?term=rs12800853), [rs11608109](http://www.ncbi.nlm.nih.gov/snp/?term=rs11608109)) that do not reach significance in the MAF \> 0.05 sample ([Table S3A](#supp-31){ref-type="supplementary-material"}) do reach significance in the MAF \> 0.01 sample ([Table S3B](#supp-32){ref-type="supplementary-material"}), for directional selection. They barely reach significance (*P* \< 0.01) based on the MAF \> 0.01 sample in LOSITAN ([Fig. S1](#supp-1){ref-type="supplementary-material"} and [Table S3B](#supp-32){ref-type="supplementary-material"}). However if we applied more stringent detection prerequisites ("force mean *F~ST~*" and "neutral mean *F~ST~*"; increasing computational load, but also increasing convergence and lowering the bias in *F~ST~* estimation) in LOSITAN, none of these three SNPs reaches significance ([Fig. S2](#supp-2){ref-type="supplementary-material"}). The results for balancing selection in BayeScan remained nearly unchanged in the MAF \> 0.01 sample, with the exception of [rs12574471](http://www.ncbi.nlm.nih.gov/snp/?term=rs12574471), which did not reach significance ([Table S3B](#supp-32){ref-type="supplementary-material"}).

All nine SNPs detected based on MAF \> 0.05 are intron variants ([Fig. 1](#fig-1){ref-type="fig"}). Only [rs12574471](http://www.ncbi.nlm.nih.gov/snp/?term=rs12574471) (3) is mentioned in the literature because it is near a supposed recombination hotspot ([@ref-22]). [rs80215768](http://www.ncbi.nlm.nih.gov/snp/?term=rs80215768) (4) lies within a promoter flanking region; [rs74751335](http://www.ncbi.nlm.nih.gov/snp/?term=rs74751335) (7) lies within a transcription factor binding site. Nonetheless, we found no known associations for those two SNPs.

The *F~ST~* values of these nine loci indicate an overall low genetic differentiation, as well as a low differentiation between populations ([Table 2](#table-2){ref-type="table"}). This is in accordance with balancing selection acting on the gene. The differences in *F~ST~* values stem from different algorithms used by the programs.
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###### Populations of the 1,000 genomes project.

![](peerj-03-1149-g004)

  Superpopulation (code)   Population code                         Population                                                   Number of individuals
  ------------------------ --------------------------------------- ------------------------------------------------------------ -----------------------
  Africa (AFR)             ASW                                     African ancestry in Southwest USA                            61
  LWK                      Luhya in Webuye, Kenya                  97                                                           
  YRI                      Yoruba in Ibadan, Nigeria               88                                                           
  Europe (EUR)             CEU                                     Utah residents with Northern and Western European ancestry   87
  FIN                      Finnish from Finland                    93                                                           
  GBR                      British from England and Scotland       88                                                           
  IBS                      Iberian populations in Spain            14                                                           
  TSI                      Toscani in Italy                        98                                                           
  East Asia (ASN)          CHB                                     Han Chinese in Bejing, China                                 97
  CHS                      Han Chinese South                       100                                                          
  JPT                      Japanese in Tokyo, Japan                89                                                           
  America (AMR)            CLM                                     Colombians from Medellin, Colombia                           66
  MXL                      Mexican ancestry from Los Angeles USA   60                                                           
  PUR                      Puerto Ricans from Puerto Rico          55                                                           
                                                                   All populations                                              1,093
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###### The dopamine receptor 2 gene's nine candidate SNPs for balancing selection (MAF \> 0.05).

![](peerj-03-1149-g005)

  Locus (\#)                                                               Major allele (Frequency)   Minor allele (Frequency)   F~**ST**~ (Lositan)   F~**ST**~ (BayeScan)   Location
  ------------------------------------------------------------------------ -------------------------- -------------------------- --------------------- ---------------------- -------------------------------
  **[rs60599314](http://www.ncbi.nlm.nih.gov/snp/?term=rs60599314) (1)**   C (0.871)                  T (0.129)                  0.0110                0.0272                 113,306,431 (Intronic region)
  **[rs79549222](http://www.ncbi.nlm.nih.gov/snp/?term=rs79549222)** (2)   T (0.87)                   G (0.13)                   0.0106                0.0260                 113,310,340 (Intronic region)
  **[rs12574471](http://www.ncbi.nlm.nih.gov/snp/?term=rs12574471)** (3)   C (0.891)                  T (0.109)                  0.0172                0.0364                 113,316,236 (Intronic region)
  **[rs80215768](http://www.ncbi.nlm.nih.gov/snp/?term=rs80215768)** (4)   G (0.925)                  A (0.075)                  0.0304                0.0328                 113,318,880 (Intronic region)
  **[rs76581995](http://www.ncbi.nlm.nih.gov/snp/?term=rs76581995)** (5)   C (0.925)                  A (0.075)                  0.0304                0.0328                 113,319,835 (Intronic region)
  **[rs80014933](http://www.ncbi.nlm.nih.gov/snp/?term=rs80014933)** (6)   T (0.923)                  C (0.077)                  0.0304                0.0332                 113,328,135 (Intronic region)
  **[rs74751335](http://www.ncbi.nlm.nih.gov/snp/?term=rs74751335)** (7)   G (0.915)                  C (0.085)                  0.0266                0.0322                 113,328,810 (Intronic region)
  **[rs77264605](http://www.ncbi.nlm.nih.gov/snp/?term=rs77264605)** (8)   A (0.915)                  G (0.085)                  0.0266                0.0327                 113,328,913 (Intronic region)
  **[rs76499333](http://www.ncbi.nlm.nih.gov/snp/?term=rs76499333)** (9)   G (0.925)                  A (0.075)                  0.0299                0.0327                 113,329,449 (Intronic region)

The Linkage Disequilibrium measurements *D*′ and *r*^2^ were used. The heat maps for all nine populations are shown in the supplementary material ([Figs. S3](#supp-3){ref-type="supplementary-material"}--[S15](#supp-15){ref-type="supplementary-material"} for *D*′ and [Figs. S16](#supp-16){ref-type="supplementary-material"}--[S28](#supp-28){ref-type="supplementary-material"} for *r*^2^). The relative position of the marked SNPs change because different populations had different SNPs excluded (see [Table S1](#supp-29){ref-type="supplementary-material"} for the list).

Discussion
==========

We found nine SNPs to be candidates for balancing selection based on the sample MAF \> 0.05; of those, two had been also detected under balancing selection based on the MAF \> 0.01 sample. We found no SNPs based on the MAF \> 0.05 sample and the MAF \> 0.01 sample, under directional selection, that are detected by both algorithms (on *P* \< 0.001 in LOSITAN) and if more stringent detection criteria were applied in LOSITAN. We therefore conclude that, if directional selection has been acting on *DRD2*, then the signs are rather weak, i.e., too weak to make definitive conclusions.

Checking all nine SNPs under balancing selection based on the MAF \> 0.05 sample with Ensembl reveals that they are all intronic region variants. For [rs60599314](http://www.ncbi.nlm.nih.gov/snp/?term=rs60599314) (1) and [rs79549222](http://www.ncbi.nlm.nih.gov/snp/?term=rs79549222) (2) that are found by LOSITAN and BayeScan on both the MAF \>0.05 sample and the MAF \>0.01 sample, no particular additional information is known. We therefore suggest that these two SNPs may provide interesting candidates for future functional studies.

[rs80215768](http://www.ncbi.nlm.nih.gov/snp/?term=rs80215768) (4) lies within a promoter flanking region and [rs74751335](http://www.ncbi.nlm.nih.gov/snp/?term=rs74751335) (7) lies within a transcription factor binding site (TFBS) (both SNPs detected based on the MAF \>0.05 sample). Many studies are available on the possible effects of mutations in such regions ([@ref-24]; [@ref-26]; or for a more general review on the topic, [@ref-28]). Nonetheless, the SNPs show low *F~ST~* values, which is congruent with the finding of balancing selection. Sewall Wright's guidelines for interpreting *F~ST~* values suggest little genetic differentiation in our populations (as cited by [@ref-29]; Chapter 5, Box 5.2). As silent mutations in *DRD2* are known to alter the mRNA stability and even the synthesis of the receptor itself ([@ref-16]), we call for exploring the possible effects of these SNPs.

Additionally, the levels of the linkage disequilibrium measurement *D*′ are typical for the respective populations: African populations show a dispersed pattern and no clear LD blocks ([Figs. S3](#supp-3){ref-type="supplementary-material"}, [S11](#supp-11){ref-type="supplementary-material"}, and [S15](#supp-15){ref-type="supplementary-material"}). While the LD blocks are visible in American populations ([Figs. S7](#supp-7){ref-type="supplementary-material"}, [S12](#supp-12){ref-type="supplementary-material"} and [S13](#supp-13){ref-type="supplementary-material"}), they are not as clear as in Asian ([Figs. S5](#supp-5){ref-type="supplementary-material"}, [S6](#supp-6){ref-type="supplementary-material"} and [S10](#supp-10){ref-type="supplementary-material"}) or European populations ([Figs. S4](#supp-4){ref-type="supplementary-material"}, [S8](#supp-8){ref-type="supplementary-material"}, [S9](#supp-9){ref-type="supplementary-material"} and [S14](#supp-14){ref-type="supplementary-material"}). Our candidate SNPs are part of tight LD blocks (*D*′ \> 0.8), which prevents us from making any further interpretations. We also examined the measurement *r*^2^ for all populations (again, excluded SNPs are listed in [Table S1](#supp-29){ref-type="supplementary-material"}), which revealed no new insight.

The finding of balancing selection suggests that in our sample the minor alleles bear some fitness disadvantage. Note that some individuals are homozygous for the minor allele (0.8--2.3% per SNP, over all populations). Fitness is altered if survival or reproduction of an organism is affected. This raises the possibility of a connection between our candidate SNPs and diseases or malfunctions of dopamine receptor 2. In the list of diseases associated with dopamine (see "Introduction") the most striking example is schizophrenia because dopamine receptor 2 blockers can successfully treat patients.

Albeit we aim to avoid overhasty conclusions regarding directional selection on *DRD2*, the three SNPs detected by BayeScan under positive selection---and that are found by LOSITAN just below significance---could be of interest. This is particularly the case for [rs6277](http://www.ncbi.nlm.nih.gov/snp/?term=rs6277), with its known phenotypic associations: [rs6277](http://www.ncbi.nlm.nih.gov/snp/?term=rs6277) has been associated with schizophrenia in Han Chinese in Taiwan ([@ref-22]), in Russians ([@ref-34]) and in Bulgarians ([@ref-8]).

Nonetheless, [rs6277](http://www.ncbi.nlm.nih.gov/snp/?term=rs6277) was not identified among the 108 schizophrenia-associated loci that have recently been published based on 36,989 cases and 113,075 controls by the *Schizophrenia Working Group of the Psychiatry Genomics Consortium* ([@ref-39]). Nevertheless, *DRD2* is one of the genes that was confirmed as being associated with schizophrenia by the *Working Group*. Thus, even weak signs of directional selection on *DRD2* might be important to (i) identify potential new disease-related phenotypical associations and (ii) to speculate on what the "selective force" could have been bringing mutations on *DRD2* towards fixations and (iii) what potential condition-related consequences selection on *DRD2* could have. The question is whether these conditions affect fitness. Accordingly, [@ref-5] showed that reproductive fitness is reduced in groups of familial schizophrenia, which suggests a selection process. Puzzlingly enough, they also found some evidence for an increased fitness of a small subsample of sisters. [@ref-41] proposed that schizophrenia is the low-fitness trait of a highly variable mental trait. They argue that the persistence of the illness at about 1% globally is too high for new mutations. Thus, mainly balancing selection would fit this hypothesis very well, and our candidate SNPs under balancing selection could be viable indicators for this.

*DRD2* is clearly associated with schizophrenia. Schizophrenia, however, is a "polygenic condition" including genetic loci over the whole human genome ([@ref-39]). Accordingly, the importance of *DRD2* should not be over-estimated. Moreover, the method of selection detection does not allow direct inferences about a phenotype (e.g., schizophrenia). Our overall results can serve as a valuable precursor to future studies on the subject.

To untangle the possible effects of our SNPs, we propose a study in which our candidate SNPs are investigated in schizophrenic and non-schizophrenic persons. A simple comparison of the SNPs and the different haplotypes between the two groups should efficiently help assess our findings. If this proposed study finds differences in those two groups, then the mechanisms of those SNPs and their possible haplotypes must be investigated.

Conclusion
==========

We found nine candidates for balancing selection on *DRD2* but only a weak signs for directional selection. Interestingly, [rs6277](http://www.ncbi.nlm.nih.gov/snp/?term=rs6277), a SNP known to be associated with schizophrenia, is among those SNPs for which we found weak evidence for directional selection. Some of the SNPs under balancing selection are potentially associated with various diseases. These SNPs could be important as biomarkers due to their very low *F~ST~* values: the genetic differentiation of one population compared with the whole sample is very small. While all candidate SNPs may be worth exploring, we definitely recommend using [rs60599314](http://www.ncbi.nlm.nih.gov/snp/?term=rs60599314) and [rs79549222](http://www.ncbi.nlm.nih.gov/snp/?term=rs79549222) (as these were detected under balancing selection based on a MAF \>0.05 and a MAF \>0.01 sample). We also recommend [rs80215768](http://www.ncbi.nlm.nih.gov/snp/?term=rs80215768) and [rs74751335](http://www.ncbi.nlm.nih.gov/snp/?term=rs74751335), found under balancing selection, for further studies on *DRD2* because the former within a promoter flanking region and the latter lies in a transcription factor binding site.

Supplemental Information
========================
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###### LOSITAN output for the MAF \> 0.01 sample

*X*-axis: estimated heterozygosity values. *Y*-axis: *F~ST~*-values. The red area indicates positive directional selection, the grey area indicates neutrality, and the yellow area indicates balancing selection. Confidence intervals represent borders between "selection areas".

###### 

Click here for additional data file.
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###### LOSITAN output for the MAF \> 0.01 sample, with more stringent criteria applied ("force mean *F~ST~*" and "neutral mean *F~ST~*")

*X*-axis: estimated heterozygosity values. *Y*-axis: *F~ST~*-values. The red area indicates positive directional selection, the grey area indicates neutrality, and the yellow area indicates balancing selection. Confidence intervals represent borders between "selection areas".
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Click here for additional data file.
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###### *D*′ heat map of the ASW population

###### 

Click here for additional data file.
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###### *D*′ heat map of the CEU population
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Click here for additional data file.
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###### *D*′ heat map of the CHB population
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Click here for additional data file.
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###### *D*′ heat map of the CHS population
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Click here for additional data file.
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###### *D*′ heat map of the CLM population
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Click here for additional data file.
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###### *D*′ heat map of the FIN population
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Click here for additional data file.
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###### *D*′ heat map of the GBR population
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Click here for additional data file.
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###### *D*′ heat map of the JPT population
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Click here for additional data file.
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###### *D*′ heat map of the LWK population
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Click here for additional data file.
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###### *D*′ heat map of the MXL population
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Click here for additional data file.
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###### *D*′ heat map of the PUR population
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Click here for additional data file.
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###### *D*′ heat map of the TSI population
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Click here for additional data file.
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###### *D*′ heat map of the YRI population
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Click here for additional data file.
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###### *r*^2^ heat map of the ASW population
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Click here for additional data file.
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###### *r*^2^ heat map of the CEU population
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Click here for additional data file.
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###### *r*^2^ heat map of the CHB population
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Click here for additional data file.
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###### *r*^2^ heat map of the CHS population
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Click here for additional data file.
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###### *r*^2^ heat map of the CLM population
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Click here for additional data file.
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###### *r*^2^ heat map of the FIN population
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Click here for additional data file.
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###### *r*^2^ heat map of the GBR population
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Click here for additional data file.
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###### *r*^2^ heat map of the JPT population

###### 

Click here for additional data file.
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###### *r*^2^ heat map of the LWK population

###### 

Click here for additional data file.
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###### *r*^2^ heat map of the MXL population

###### 

Click here for additional data file.
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###### *r*^2^ heat map of the PUR population

###### 

Click here for additional data file.
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###### *r*^2^ heat map of the TSI population

###### 

Click here for additional data file.
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###### *r*^2^ heat map of the YRI population

###### 

Click here for additional data file.
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###### SNPs that caused the LD calculations of R to fail

These SNPs were excluded from the LD calculations. The population IBS was excluded entirely because 30 SNPs were flawed (which is nearly 20% of all SNPs).

###### 

Click here for additional data file.
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###### Results of LOSITAN (left) and BayeScan (right) for all 151 SNPs of *DRD2* (MAF \> 0.05)

*P*, *P* (Simulation *F~ST~* \< sample*F~ST~*); He, expected heterozygosity; *F~ST~*, Fixation Indices subpopulation to total population. *P*, posterior probability; log10 (PO), logarithm (base 10) of the posterior odds; *q*-value, false discovery rate (FDR) analogue of the *P* value; *α~i~* = locus-specific component (negative alpha suggests balancing selection, while positive alpha suggests directional selection); *F~ST~*, Fixation Indices subpopulation to total population. ∗---the value of 1,000 means infinity (see BayeScan manual).

###### 

Click here for additional data file.
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###### Candidate loci under selection in the MAF \> 0.05 sample, plus the candidates of the MAF \> 0.01 sample

Comparison of the candidate loci under selection found both samples; (a) shows the calculations of the MAF \> 0.05 sample and the (b) the calculations of the MAF \> 0.01 sample. *P*, *P* (Simulation *F~ST~* \< sample *F~ST~*); He, expected heterozygosity; *F~ST~*, Fixation Indices subpopulation to total population. *P*, posterior probability; log10 (PO), logarithm (base 10) of the posterior odds; *q*-value, false discovery rate (FDR) analogue of the *P* value; *α~i~*, locus-specific component (negative alpha suggests balancing selection, while positive alpha suggests directional selection); *F~ST~*, Fixation Indices subpopulation to total population.

###### 

Click here for additional data file.
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###### Candidate loci under selection in the MAF \> 0.01 sample, plus the candidates of the MAF \> 0.05 sample

Comparison of the candidate loci under selection found both samples; (a) shows the calculations of the MAF \> 0.05 sample and the (b) the calculations of the MAF \> 0.01 sample. *P P* (Simulation *F~ST~* \< sample *F~ST~*); He, expected heterozygosity; *F~ST~*, Fixation Indices subpopulation to total population. *P*, posterior probability; log10 (PO), logarithm (base 10) of the posterior odds; *q*-value, false discovery rate (FDR) analogue of the *P* value; *α~i~*, locus-specific component (negative alpha suggests balancing selection, while positive alpha suggests directional selection); *F~ST~*, Fixation Indices subpopulation to total population.

###### 

Click here for additional data file.
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###### CONVERT datafile of the MAF \> 0.05 sample

###### 

Click here for additional data file.
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###### CONVERT datafile of the MAF \> 0.01 sample

###### 

Click here for additional data file.
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